Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04675853 · ClinicalTrials.gov registry record
Rapid dEvice Testing pROtocol for Parkinson's Disease
A clinical trial, sponsored by HealthMode.
- Completed
- Registry status
- 12
- Enrollment target
NCT04675853: Completed study, sponsored by HealthMode.
NCT04675853 is a clinical trial that has completed, run by HealthMode. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04675853 has completed, sponsored by HealthMode.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
This is an 8 week observational study to evaluate the feasibility of using remote monitoring technologies in future studies of PD. The study will 2 clinical evaluations (one initial, one final), and an 8-week monitoring period including 4 virtual visits where participants will use a combination of digital devices (Emerald touchless sensor system with associated ankle accelerometer, iPhone, Apple Watch, iPad, Fitbit Aria, FitBit Versa, Withings Blood Pressure Monitor Connect, and/or Withings Sleep Mat) during their daily lives.
Primary Outcome
determined by evaluating: 1. Ease of deployment and initial set-up, utility of technology and user experience as reported by the usability surveys and interview questionnaires (measured by means of Standard Usability Questionnaire score ranges from 10 to 50, higher score indicating a better usability) 2. Total time and percentage of continuous data collection for each stream of data and frequency and distribution of missing data points. 3. Mutual consistency of data from multiple, related data
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2020-11-25 |
| Est. Completion | 2021-11-25 |
What the finished NCT04675853 record still lists
NCT04675853 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04675853 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04675853 about?
NCT04675853 is a clinical study titled "Rapid dEvice Testing pROtocol for Parkinson's Disease". This is an 8 week observational study to evaluate the feasibility of using remote monitoring technologies in future studies of PD. The study will 2 clinical evaluations (one initial, one final), and an 8-week monitoring period including 4 virtual visits where participants will use a combination of d...
What is the current status of trial NCT04675853?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2020-11-25. Estimated completion is 2021-11-25.
Who is sponsoring clinical trial NCT04675853?
This trial is sponsored by HealthMode, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI